95209-84-0

Basic information

• Product Name: 1(6H)-Pyridazineaceticacid,6-oxo-(6CI,9CI)
• Synonyms: 1(6H)-Pyridazineaceticacid,6-oxo-(6CI,9CI);6-oxo-1(6H)-Pyridazineacetic acid;2-(6-OXO-1,6-DIHYDROPYRIDAZIN-1-YL)ACETIC ACID;(6-oxopyridazin-1(6{H})-yl)acetic acid;2-(6-OxopyridaziN-1-Yl)Acetic Acid
• CAS NO: 95209-84-0
• Molecular Formula: C₆H₆N₂O₃
• Molecular Weight: 154.12344
• Product Categories: GLYCINESCAFFOLD
• Mol File: 95209-84-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1(6H)-Pyridazineaceticacid,6-oxo-(6CI,9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1(6H)-Pyridazineaceticacid,6-oxo-(6CI,9CI)(95209-84-0)
• EPA Substance Registry System: 1(6H)-Pyridazineaceticacid,6-oxo-(6CI,9CI)(95209-84-0)

Safety Data

• Hazardous Substances Data: 95209-84-0(Hazardous Substances Data)

Usage

General Description

1(6H)-Pyridazineacetic acid, 6-oxo-(6CI,9CI) is a chemical compound with the molecular formula C6H5N2O3. It is a derivative of pyridazine and belongs to the family of pyridazines. 1(6H)-Pyridazineaceticacid,6-oxo-(6CI,9CI) is characterized by its 6-oxo functional group attached to the pyridazine ring. It is used as a building block in organic synthesis and pharmaceutical research. The compound has potential applications in the development of new drugs and pharmaceuticals due to its unique chemical structure and properties.

Upstream product

• 89581-61-3 2-[6-chloro-pyridazin-3(2H)-one-2-yl]-acetic acid 
• 874491-58-4 ethyl 2-(6-oxopyridazin-1(6H)-yl)acetate 
• 504-30-3 2H-Pyridazin-3-one 
• 79-11-8 chloroacetic acid 

Relevant articles and documents

Nitrogen heterocyclic ring group substituted amide derivative and application thereof

The invention discloses a nitrogen heterocyclic ring group substituted amide derivative and application thereof, particularly relates to a novel nitrogen heterocyclic ring group substituted amide derivative and a drug composition comprising the compound, and further relates to methods for preparing the compound and the drug composition, and application of the compound and the drug composition to preparation of drugs for treating diseases or symptoms, particularly overactive bladder, excited and mediated by beta 3-adrenergic receptors. The compound and the drug composition can be used for activating the beta 3-adrenergic receptors.

HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS

The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.

Preparation and biological effects of N-TRIS(hydroxymethyl)methylaminocarbonylmethyl derivatives of heterocyclic bases

-